STOCK TITAN

Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Evogene Ltd. (EVGN) to Release Q2 2023 Financial Results and Host Conference Call
Positive
  • None.
Negative
  • None.

Conference call scheduled for 9:00 AM ET

REHOVOT, Israel, Aug. 1, 2023 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN)(TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that it will release its financial results for the second quarter of 2023, on Thursday, August 17, 2023.

Evogene Logo

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference call, please use the following numbers: +1-888-281-1167 toll-free from the United States or +972-3-918-0609 internationally. You can also find access details for the call at https://evogene.com/investor-relations/presentations-and-webcasts/

A replay of the conference call will be available approximately two hours following the completion of the call. To access the replay, please dial +1-888-326-9310 toll-free from the United States or +972-3-925-5901 internationally. The telephone replay will be accessible for three days, but an archive of the webcast will be available from the webcast link for the following twelve months.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AIChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its five subsidiaries including:

1.  Biomica Ltd. (www.biomicamed.com) developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;

2.  Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome based ag-biologicals powered by MicroBoost AI;

3.  AgPlenus Ltd. (www.agplenus.com) -developing next generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;

4.  Canonic Ltd. (www.canonicbio.com) – developing medical cannabis products based on decoding plant genetics for optimized therapeutic effect powered by GeneRator AI; and

5.  Casterra Ag Ltd. (www.casterra.co)– developing and marketing superior castor seed varieties producing high yield and high-grade oil content, on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Contacts

Rachel Pomerantz Gerber

Head of Investor Relations at Evogene

rachel.pomerantz@evogene.com

Tel: +972-8-9311901

Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2023-financial-results-release--conference-call-for-august-17-2023-301890215.html

SOURCE Evogene

FAQ

When will Evogene Ltd. release its financial results for Q2 2023?

Evogene Ltd. will release its financial results for the second quarter of 2023 on Thursday, August 17, 2023.

What time will the conference call to discuss the financial results take place?

The conference call to discuss the financial results will take place at 9:00 AM Eastern Time on Thursday, August 17, 2023.

How can I join the conference call?

To join the conference call, please use the following numbers: +1-888-281-1167 toll-free from the United States or +972-3-918-0609 internationally. Access details can also be found at https://evogene.com/investor-relations/presentations-and-webcasts/

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be available approximately two hours following the completion of the call. The telephone replay will be accessible for three days, and an archive of the webcast will be available from the webcast link for the following twelve months.

EVOGENE LTD.

NASDAQ:EVGN

EVGN Rankings

EVGN Latest News

EVGN Stock Data

9.12M
5.37M
1.66%
7.87%
0.5%
Biotechnology
Healthcare
Link
United States of America
Rehovot